Gilead Sciences GILD
US equityMarket cap rank #82Drug Manufacturers - GeneralCAR-T TherapyInfectious DiseaseCancer Research
$166.89 −$0.68 (-0.41%)
Market closed · Nov 6, 8:20 pm ET · Last extended-hours $166.89 0.00%
Open$164.11
Prev close$167.57
Day range$164.00 – $169.06
Volume5.82M
Market cap$207.00B
P/E (TTM)–
Dividend yield1.95%
Analyst view
ConsensusBuy
Analysts18
Average target$180.19+8.0% vs. price
- Buy 94%
- Hold 6%
Low $145.00Now $166.89Avg $180.19High $200.00
Recent rating changes
The last 20 actions on file set price targets from $160.00 to $200.00, averaging $184.50.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 5 Nov 2026 | Maxim Group | BUY | – |
| 5 Nov 2026 | Scotiabank | BUY | $200.00 |
| 4 Nov 2026 | Citi | BUY | $188.00 |
| 2 Nov 2026 | BMO Capital | BUY | $184.00 |
| 30 Oct 2026 | TD Cowen | BUY | $175.00 |
| 30 Oct 2026 | Wells Fargo | BUY | $190.00 |
| 30 Oct 2026 | UBS | BUY | $195.00 |
| 30 Oct 2026 | Truist Financial | BUY | $181.00 |
| 30 Oct 2026 | Scotiabank | BUY | $200.00 |
| 30 Oct 2026 | Morgan Stanley | BUY | $183.00 |
| 30 Oct 2026 | Evercore | BUY | – |
| 30 Oct 2026 | Needham | BUY | $200.00 |
| 30 Oct 2026 | BMO Capital | BUY | $184.00 |
| 30 Oct 2026 | Citi | BUY | $188.00 |
| 30 Oct 2026 | J.P. Morgan | BUY | $190.00 |
| 29 Oct 2026 | Cantor Fitzgerald | BUY | $175.00 |
| 29 Oct 2026 | Wells Fargo | BUY | $165.00 |
| 29 Oct 2026 | Citi | BUY | $188.00 |
| 25 Oct 2026 | Bernstein | BUY | $160.00 |
| 22 Oct 2026 | UBS | BUY | $175.00 |
No comments yet — be the first to weigh in on GILD.
Sign in to join the discussion.